Periodic Reporting for period 1 - NANOLIGO (Nanostar Sieving for Oligonucleotide Therapeutics)

Summary
Oligonucleotide therapeutics (oligos) treat disease at the RNA-level, enabling targets to be reached beyond those generally accessible to conventional pharmaceuticals. Since the Nobel Prize winning discovery of small interfering RNA (siRNA), its specificity and selectivity...